Oncology Institute (DFPH) Short term Debt (2020 - 2021)

Oncology Institute's (DFPH) quarterly Short term Debt came in at $183000.0 in Q4 2021, down 96.59% YoY from $5.4 million in Q4 2020, and down 96.59% on a QoQ basis from $5.4 million in Q4 2020.

Oncology Institute (DFPH) Short term Debt (2020 - 2021) Analysis & Trends

Oncology Institute (DFPH) has 2 years of Short term Debt data on file, last reported at $183000.0 in Q4 2021.

  • Quarterly Short term Debt fell 96.59% year-over-year to $183000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $183000.0 (down 96.59% YoY) and the FY2021 annual result came in at $183000.0, down 96.59% from the prior year.
  • Short term Debt fell to $183000.0 in Q4 2021, from $5.4 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $5.4 million in Q4 2020 to a low of $183000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 88.19 Bn 90.61 Bn 15.19 Bn
2 Tenet Healthcare 21.59 Bn 21.56 Bn 4.45 Bn
3 Encompass Health 12.19 Bn 12.86 Bn 1.34 Bn
4 Davita 11.52 Bn 12.39 Bn 1.16 Bn
5 Ensign 10.59 Bn 10.27 Bn 306.24 Mn
6 Universal Health Services 8.79 Bn 8.72 Bn 3.29 Bn
7 Pacs 7.04 Bn 6.88 Bn 338.46 Mn
8 Chemed 6.96 Bn 6.92 Bn 221.47 Mn
9 Concentra Group Holdings Parent 4.52 Bn 4.38 Bn 192.10 Mn
10 Oncology Institute 201.94 Mn 160.85 Mn 27.17 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 183,000.00
Dec 31, 2020 5.37 Mn